Hackensack University Medical Center Foundation Receives Donation to Advance Multiple Myeloma Research

The Hackensack University Medical Center Foundation has received a substantial donation from Celgene Corporation to advance multiple myeloma research and transformational medicine that improve patient outcomes at John Theurer Cancer Center at Hackensack University Medical Center. Supported by Celgene, a global biopharmaceutical leader in the discovery, development and delivery of treatment for diseases like multiple myeloma, funds will help to establish the Multiple Myeloma Institute  – a leading-edge research facility at the Seton Hall-Hackensack Meridian School of Medicine scheduled to open in 2018.(This story was also featured by TapInto.)